FindTrial
Sign In

The component of bone destruction are measured in relation to biting force before and after treatment.

Evaluation Of Level Of Pyridinoline Cross-Linked Carboxyterminal Telopeptide of Type 1 Collagen (ICTP ) In Occlusal Trauma Patients Before And After Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/08/045081
Enrollment
20
Registered
2022-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K030- Excessive attrition of teeth

Interventions

Intervention1: Occlusal splint: Different types of occlusal splint. Control Intervention1: Pyridinoline Cross-Linked Carboxyterminal Telopeptide of Type 1 Collagen (ICTP ): levels of Pyridinoline Cros

Sponsors

DrSathya Prathiba P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with occlusal trauma (clinically occlusal wear facet and radiographically funnel shaped boneloss)

Exclusion criteria

Exclusion criteria: � Patients who are not willing to participate in the study � Exclusion of third molars. � Patients with any systemic diseases � Smokers

Design outcomes

Primary

MeasureTime frame
to evaluate the levels of bone destruction marker ICTP in GCFTimepoint: At baseline, 1week and 1 month—

Secondary

MeasureTime frame
to evaluate the treatment out come of occlusal splint.Timepoint: 1 week and 1 month—

Countries

India

Contacts

Public ContactDr Sathya PrathibaP

Karpaga Vinayaga Institute of Dental Sciences

anizmds@gmail.com9884904310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026